BOLT vs RL · rev $7.7M vs P/E 24, rev $8.11B
Bolt Biotherapeutics (BOLT) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
BOLT currently screens at market cap $11.3M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the BOLT and RL stock pages for the full models.
Not investment advice.